Read the Tirzepatide Research Guide. Review the research context and evidence limitations.
Tirzepatide (10 mg Vial) is supplied for controlled laboratory evaluation of Tirzepatide within Weight Loss / Metabolic Research studies.
- Research material: Tirzepatide
- Listed strength and format: 10 mg Vial
- Research category: Weight Loss / Metabolic Research
Tirzepatide 10 mg research identity
Tirzepatide, studied under the identifier LY3298176, is a dual GIP and GLP-1 receptor agonist. The original compound-characterization study includes receptor assays, mouse experiments and early clinical research. This listing supplies 10 mg total material per vial; the study is not a test of this SRP lot.
For a different compound profile, review RTZ-GLP3 / retatrutide research vials. Vial amounts alone do not establish equivalence between compounds. Contact SRP for Tirzepatide product questions.
For laboratory research only. Not for human or animal use, consumption, administration, diagnosis, treatment, or therapeutic application.
Reviews
There are no reviews yet.